The_Oxford_Health_Company - Accounts


Company registration number 08415762 (England and Wales)
The Oxford Health Company Ltd
Unaudited financial statements
For the year ended 28 February 2022
The Oxford Health Company Ltd
Contents
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 8
The Oxford Health Company Ltd
Statement of financial position
As at 28 February 2022
28 February 2022
- 1 -
2022
2021
Notes
£
£
£
£
Fixed assets
Intangible assets
3
11,388
10,952
Tangible assets
4
817,258
683,382
828,646
694,334
Current assets
Stocks
765,022
371,630
Debtors
5
891,903
875,114
Cash at bank and in hand
692,906
314,525
2,349,831
1,561,269
Creditors: amounts falling due within one year
6
(1,350,154)
(943,677)
Net current assets
999,677
617,592
Total assets less current liabilities
1,828,323
1,311,926
Creditors: amounts falling due after more than one year
7
(549,452)
(435,203)
Provisions for liabilities
(114,700)
(89,100)
Net assets
1,164,171
787,623
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
1,164,071
787,523
Total equity
1,164,171
787,623

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 28 February 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Oxford Health Company Ltd
Statement of financial position (continued)
As at 28 February 2022
28 February 2022
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 22 June 2022 and are signed on its behalf by:
Mr T E G Humphrey
Director
Company Registration No. 08415762
The Oxford Health Company Ltd
Notes to the financial statements
For the year ended 28 February 2022
- 3 -
1
Accounting policies
Company information

The Oxford Health Company Ltd is a private company limited by shares incorporated in England and Wales. The registered office is The Glades, Festival Way, Festival Park, Stoke-on-Trent, Staffordshire, United Kingdom, ST1 5TQ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
ten years.
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

The Oxford Health Company Ltd
Notes to the financial statements (continued)
For the year ended 28 February 2022
1
Accounting policies
(Continued)
- 4 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
20% on cost
Fixtures and fittings
20% or 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Stocks

Stocks are stated at the lower of cost and net realisable value (estimated selling price less costs to complete and sell). Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing stock to its present location and condition. Cost is calculated using the first-in, first-out formula. Provision is made for damaged, obsolete and slow-moving stock where appropriate.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences. Such liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax liabilities are offset when the company has a legally enforceable right to offset current tax liabilities and the deferred tax liabilities relate to taxes levied by the same tax authority.

1.8
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

The Oxford Health Company Ltd
Notes to the financial statements (continued)
For the year ended 28 February 2022
1
Accounting policies
(Continued)
- 5 -
1.9
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the statement of financial position as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

1.10
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

1.11
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2022
2021
Number
Number
Total
42
29
The Oxford Health Company Ltd
Notes to the financial statements (continued)
For the year ended 28 February 2022
- 6 -
3
Intangible fixed assets
Patents & licences
£
Cost
At 1 March 2021
11,138
Additions
1,715
At 28 February 2022
12,853
Amortisation and impairment
At 1 March 2021
186
Amortisation charged for the year
1,279
At 28 February 2022
1,465
Carrying amount
At 28 February 2022
11,388
At 28 February 2021
10,952
4
Tangible fixed assets
Leasehold improvements
Fixtures and fittings
Total
£
£
£
Cost
At 1 March 2021
139,312
811,160
950,472
Additions
52,480
310,232
362,712
At 28 February 2022
191,792
1,121,392
1,313,184
Depreciation and impairment
At 1 March 2021
47,352
219,738
267,090
Depreciation charged in the year
31,536
197,300
228,836
At 28 February 2022
78,888
417,038
495,926
Carrying amount
At 28 February 2022
112,904
704,354
817,258
At 28 February 2021
91,960
591,422
683,382
The Oxford Health Company Ltd
Notes to the financial statements (continued)
For the year ended 28 February 2022
- 7 -
5
Debtors
2022
2021
Amounts falling due within one year:
£
£
Trade debtors
779,500
782,823
Other debtors
112,403
92,291
891,903
875,114
6
Creditors: amounts falling due within one year
2022
2021
£
£
Bank loans
49,873
266,144
Trade creditors
455,562
384,802
Taxation and social security
252,948
173,157
Other creditors
591,771
119,574
1,350,154
943,677
7
Creditors: amounts falling due after more than one year
2022
2021
£
£
Bank loans
172,091
214,790
Other creditors
377,361
220,413
549,452
435,203
Creditors which fall due after five years are as follows:
2022
2021
£
£
Payable by instalments
-
31,667
8
Secured debts

Included within bank loans is a CBILs loan of £190,000 (2021 - £190,00) which is secured by way of a fixed charge on all properties present and future, goodwill and uncalled capital and equipment, and a floating charge on the undertaking and all other property and assets of the Company.

 

Included within loans are invoice discounting facilities of £841 (2021 - £250,000), which are secured by fixed charges over the assets to which they relate.

 

Amounts due under finance leases and hire purchase contracts are secured against the assets which they relate to.

 

The Oxford Health Company Ltd
Notes to the financial statements (continued)
For the year ended 28 February 2022
- 8 -
9
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2022
2021
£
£
-
0
1,967
2022-02-282021-03-01false22 June 2022CCH SoftwareCCH Accounts Production 2022.200No description of principal activityMr James Edward AllanMr Thomas Edward George HumphreyMr Peter James Burrows084157622021-03-012022-02-28084157622022-02-28084157622021-02-2808415762core:PatentsTrademarksLicencesConcessionsSimilar2022-02-2808415762core:PatentsTrademarksLicencesConcessionsSimilar2021-02-2808415762core:LeaseholdImprovements2022-02-2808415762core:FurnitureFittings2022-02-2808415762core:LeaseholdImprovements2021-02-2808415762core:FurnitureFittings2021-02-2808415762core:CurrentFinancialInstrumentscore:WithinOneYear2022-02-2808415762core:CurrentFinancialInstrumentscore:WithinOneYear2021-02-2808415762core:Non-currentFinancialInstrumentscore:AfterOneYear2022-02-2808415762core:Non-currentFinancialInstrumentscore:AfterOneYear2021-02-2808415762core:CurrentFinancialInstruments2022-02-2808415762core:CurrentFinancialInstruments2021-02-2808415762core:Non-currentFinancialInstruments2022-02-2808415762core:Non-currentFinancialInstruments2021-02-2808415762core:ShareCapital2022-02-2808415762core:ShareCapital2021-02-2808415762core:RetainedEarningsAccumulatedLosses2022-02-2808415762core:RetainedEarningsAccumulatedLosses2021-02-2808415762bus:Director22021-03-012022-02-2808415762core:IntangibleAssetsOtherThanGoodwill2021-03-012022-02-2808415762core:PatentsTrademarksLicencesConcessionsSimilar2021-03-012022-02-2808415762core:LeaseholdImprovements2021-03-012022-02-2808415762core:FurnitureFittings2021-03-012022-02-28084157622020-03-012021-02-2808415762core:PatentsTrademarksLicencesConcessionsSimilar2021-02-2808415762core:PatentsTrademarksLicencesConcessionsSimilarcore:ExternallyAcquiredIntangibleAssets2021-03-012022-02-2808415762core:LeaseholdImprovements2021-02-2808415762core:FurnitureFittings2021-02-28084157622021-02-2808415762core:WithinOneYear2022-02-2808415762core:WithinOneYear2021-02-2808415762bus:PrivateLimitedCompanyLtd2021-03-012022-02-2808415762bus:SmallCompaniesRegimeForAccounts2021-03-012022-02-2808415762bus:FRS1022021-03-012022-02-2808415762bus:AuditExemptWithAccountantsReport2021-03-012022-02-2808415762bus:Director12021-03-012022-02-2808415762bus:Director32021-03-012022-02-2808415762bus:FullAccounts2021-03-012022-02-28xbrli:purexbrli:sharesiso4217:GBP